Abbott infant formula lawsuit results in a $53 million jury verdict in the United States over NEC-related claims in a premature infant case. The ruling adds to ongoing litigation involving infant formula manufacturers and increasing scrutiny around neonatal nutrition products, medical risks, and regulatory standards.
Abbott has launched the FreeStyle Libre 3 Plus in Australia, the world’s smallest continuous glucose monitor. About the size of a $2 coin, the sensor sits on your upper arm, sends readings to your phone, and connects with the mylife YpsoPump insulin pump for automatic insulin adjustments. It can be worn for up to 15 days and is covered under Australia’s National Diabetes Services Scheme for people with type 1 diabetes. For Australians managing diabetes every day, this is one of the most practical and discreet options available yet.
Copyright@ 2026 Inspirepreneurmagazine. All Rights Reserved.
